Showing results 1 to 8 of 8
Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma Park, Junseong; Kim, Chang Gon; Shim, Jin-Kyoung; Kim, Jong Hoon; Lee, Hoyoung; Lee, Jae Eun; Kim, Min Hwan; et al, ONCOIMMUNOLOGY, v.8, no.1, 2019-01 |
Exploring the brain epitranscriptome: perspectives from the NSAS summit Lee, Sung-Min; Koo, Bonsang; Carre, Clement; Fischer, Andre; He, Chuan; Kumar, Ajeet; Liu, Kathy; et al, FRONTIERS IN NEUROSCIENCE, v.17, 2023-10 |
Harnessing type I interferon-mediated immunity to target malignant brain tumors Lim, Juhee; Kang, In; La, Jeongwoo; Ku, Keun Bon; Kang, Byeong Hoon; Kim, Yumin; Park, Won Hyung; et al, FRONTIERS IN IMMUNOLOGY, v.14, 2023-05 |
Human allogenic gamma delta T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands Choi, Haeyoun; Lee, Yunkyung; Park, Soon A.; Lee, Ji Hyeon; Park, Junseong; Park, Jang Hyun; Lee, Heung Kyu; et al, ONCOIMMUNOLOGY, v.11, no.1, 2022-12 |
Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination You, Hye Jin; Park, Ho-Young; Kim, Jinkuk; Lee, In-Hee; Seol, Ho Jun; Lee, Jung-Il; Kim, Sung Tae; et al, MEDICINE, v.95, no.27, 2016-07 |
Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma Kong, Doo-Sik; Kim, Jinkuk; Lee, In-Hee; Kim, Sung Tae; Seol, Ho Jun; Lee, Jung-Il; Park, Woong-Yang; et al, ONCOTARGET, v.7, no.10, pp.11526 - 11538, 2016-03 |
Supplementation with a high-glucose drink stimulates anti-tumor immune responses to glioblastoma via gut microbiota modulation Kim, Jaeho; Kim, Yumin; La, Jeongwoo; Park, Won Hyung; Kim, Hyun-Jin; Park, Sang Hee; Ku, Keun Bon; et al, CELL REPORTS, v.42, no.10, 2023-10 |
γδ T cells as a potential therapeutic agent for glioblastoma Kang, In; Kim, Yumin; Lee, Heung Kyu, FRONTIERS IN IMMUNOLOGY, v.14, 2023-10 |
Discover